Hypoparathyroidism
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Upon obtaining informed consent: (1) Patients >= 18 years of age (2) patients with a confirmed diagnosis of hypoparathyroidism (3) Previously treated with activated vitamin D (4) Patients with laboratory data for serum calcium, * serum phosphorus, and intact PTH (5) Patients who can voluntarily consent to participate in the study *Basically, an albumin-corrected value will be used, but if not available, a corrected calcium value will be calculated from the serum calcium value using Payne's formula. - Payne's formula: corrected Ca level (mg/dL) = measured Ca level (mg/dL) + (4 -Alb level (g/dL)) At enrollment: (1) Experienced distress due to hypoparathyroidism
Exclusion criteria
Exclusion criteria: Upon obtaining informed consent: (1) Diagnosis of pseudohypoparathyroidism (2) Patients considered by physician to be ineligible
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Burden of Disease (Physical, Emotional, and Social Aspects) - Treatment Burden (Traditional Pain Points) | — |
Countries
Japan
Contacts
Department of Internal Medicine, Kurume University School of Medicine Division of Endocrine and metabolic disease